Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

rocuronium bromide, Quantity: 10 g/L

Available from:

Fresenius Kabi Australia Pty Ltd

INN (International Name):

Rocuronium bromide

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Administration route:

Intravenous

Units in package:

10 x 5mL, 5 x 5mL

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Product summary:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-11-12